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Abstract
Identifying protein surface regions preferentially recognizable by antibodies (antigenic epitopes) is at the heart of new
immuno-diagnostic reagent discovery and vaccine design, and computational methods for antigenic epitope prediction
provide crucial means to serve this purpose. Many linear B-cell epitope prediction methods were developed, such as
BepiPred, ABCPred, AAP, BCPred, BayesB, BEOracle/BROracle, and BEST, towards this goal. However, effective immunological
research demands more robust performance of the prediction method than what the current algorithms could provide. In
this work, a new method to predict linear antigenic epitopes is developed; Support Vector Machine has been utilized by
combining the Tri-peptide similarity and Propensity scores (SVMTriP). Applied to non-redundant B-cell linear epitopes
extracted from IEDB, SVMTriP achieves a sensitivity of 80.1% and a precision of 55.2% with a five-fold cross-validation. The
AUC value is 0.702. The combination of similarity and propensity of tri-peptide subsequences can improve the prediction
performance for linear B-cell epitopes. Moreover, SVMTriP is capable of recognizing viral peptides from a human protein
sequence background. A web server based on our method is constructed for public use. The server and all datasets used in
the current study are available at http://sysbio.unl.edu/SVMTriP.
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Introduction
By secreting antibodies against antigens, B-cells play an
important role in the immune system to fight an invasive
pathogenic organism or substance. Antigenic epitopes are regions
of the protein surface that are preferentially recognized by B-cell
antibodies [1]. Prediction of antigenic epitopes is useful for the
investigation on the mechanism of body’s self-protection systems
and could be helpful for the design of vaccine components and
immuno-diagnostic reagents [2].
Usually, B-cell antigenic epitopes are classified as either
continuous or discontinuous. A continuous (also called linear)
epitope is a consecutive fragment from the protein sequence; a
discontinuous epitope is composed of several fragments scattered
along the protein sequence, but still form an antigen-binding
interface in 3D. The boundary between continuous and discon-
tinuous epitopes is vague; a continuous fragment in a discontin-
uous epitope can be considered as a continuous epitope.
Currently, the majority of available epitope prediction methods
focus on continuous epitopes due to the relative simplicity of the
problem and the convenience of available investigation methods,
in which the amino acid sequence of a protein is taken as the
input. Such prediction methods are based upon the amino acid
properties including hydrophilicity [3,4], solvent accessibility [5],
secondary structure [6], flexibility [7], and antigenicity [8]. In
addition, based on the epitope databases such as IEDB [9], Bcipep
[10], and FIMM [11], there are also some methods using machine
learning approaches, such as Hidden Markov Model (HMM) [12],
Artificial Neural Network (ANN) [13], and Support Vector
Machine (SVM) [14,15], to locate linear epitopes, such as
PREDITOP [8,16], PEOPLE [17], BEPITOPE [18], BepiPred
[12], ABCPred [13], AAP [14], BCPred [15], BayesB [19],
BEOracle/BROracle [20], and BEST [21].
In this work, a new linear B-cell epitope prediction method is
developed using the SVM method to integrate the Tri-peptide
similarity and Propensity scores (SVMTriP). SVMTriP is tested for
varied epitope sequence lengths. With the five-fold cross-valida-
tion, SVMTriP achieves a sensitivity (Sn) of 80.1% and a precision
(P) of 55.2% for sequences with 20 amino acids (AA), which are
higher than those of AAP [14] and BCPred [15].
Results
Prediction performance
SVMTriP is trained and tested with different epitope lengths,
and for each length, the SVM parameters have their independent
optimal values. For example, for 20AA-length cases, SVMTriP
reaches its optimal performance at c=32, g=0.05, and p=0.5 for
the SVM model with Sn = 80.1% 62.1% and P=55.2% 61.0%
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at the point with the maximal F-measure, 0.693. All results are
shown in Table 1. Though, for different lengths of epitope
sequences, SVMTriP has various points with the maximal F-
measure, the precision values for different lengths are similar. The
sensitivity increases significantly as the length of the epitope
sequences becomes large. The range of the values of areas under
the receiver operating characteristic curves (AUC) is from 0.674 to
0.702. Based on results of multiple evaluation methods (Table 1),
SVMTriP for 18AA- and 20AA-length cases have the best
performance. However, one may note a fact that most of
experimental determined epitopes from IEDB [9] have less than
20 AA residues. A possible reason why SVMTriP favors long
length of sequences is a long sequence may have more tri-peptides
to show detectable frequency tendency. Another possibility is that
the epitopic amino acid residues in experimentally determined
epitopes are subsets of all real epitopic residues. Based on the
testing results, 20AA is set as the default epitope length for
SVMTriP to search for putative epitopes on the web server.
For comparison, AAP and BCPred are implemented locally
based on their method descriptions [14,15], trained/tested with
the same dataset and the five-fold cross-validation procedure for
20AA case. The results are listed in Table 2. Compared with
BCPred and AAP, SVMTriP has a similar precision value, but
significantly improved sensitivity at the point with the maximal F-
measure. Figure 1 shows the receiver operating characteristic
curve (ROC) for three methods, from which one may notice that
SVMTriP has significantly larger true positive rate than BCPred
and AAP in the region of low false positive rate. The AUC values
are 0.667, 0.667, and 0.702 for AAP, BCPred, and SVMTriP,
respectively. The AUC value of SVMTriP is significantly higher
than those from the other two methods; the p-values of
comparison against AAP and BCPred are 2.1761025 and
1.5861025, respectively.
Top weighted tri-peptides
The prediction model relies on the occurring-frequency
distribution of tri-peptides in the tri-peptide space, i.e. all
combinations of any three amino acids. In Table 3, tri-peptides
with top 20 weights in the optimal SVM model of 20AA-length
epitopes are listed. All of the top ranked tri-peptides contain
Glutamine or Proline, whereas the occurring frequencies of
Glutamine and Proline in known linear epitopes (20AA) are only
8.1% and 6.84%, respectively. In the background of over all
proteins, the occurring frequencies of Glutamine and Proline are
3.84% and 3.44% [22], which is not significantly different to the
values in linear epitopes. However, the distribution patterns of the
combined amino acids are quite different between epitopes and
non-epitope peptides. Therefore, the tri-peptides containing
Glutamine or Proline may play an important role in epitope
recognition by B-cell antibodies. The algorithm of SVMTriP
successfully utilized this difference to distinguish linear epitopes
from other parts of protein peptides.
Tendency of prediction between virus and human
proteins
Independent test of different epitope prediction methods is
challenging because of the limited number of known epitopes. In
this study, we devise an alternative independent test method. In
the training set, most epitopes are from virus or bacteria, and their
corresponding antibodies are mainly human antibodies. A basic
property of the human immune system is the capability to
distinguish any pathogenic agents, viral or bacterial, from the
innate structures of the human being. All known B-cell epitopes in
the training set came from the response of whole immune system,
including the response of CD4 T helper cells. In order to simulate
the human immune system, a successfully trained epitope
prediction method should act the same, i.e. be able to distinguish
pathogenic proteins from human proteins. In other words, the
virus proteins should be preferentially more highly scored than
human proteins by a successful prediction algorithm. To
implement this test, 105 20AA-length peptides are collected from
virus and human proteins: 56104 peptides are randomly selected
from 391,466 virus proteins and others from 81,967 human
proteins in the Refseq protein database [23]. AAP, BCPred, and
SVMTriP are applied to these virus and human peptides, and top-
ranked peptides are returned. The fractions of virus peptides in
different numbers of returned peptides are shown in Figure 2. In
Table 1. Performance of SVMTriP models with different
epitope lengths.
Length (AA) Sn (%) P (%) F-measure AUC
10 68.562.5 55.561.5 0.61560.020 0.674
12 67.563.5 57.062.0 0.62060.030 0.681
14 64.864.9 56.562.5 0.60560.030 0.689
16 63.565.5 57.163.0 0.60160.045 0.685
18 79.061.9 54.161.1 0.64160.015 0.666
20 80.162.1 55.261.0 0.69360.060 0.702
doi:10.1371/journal.pone.0045152.t001
Figure 1. ROC curves for AAP, BCPred, and SVMTriP.
doi:10.1371/journal.pone.0045152.g001
Table 2. Performance of different linear B-cell epitope
prediction methods.
Methods Sn (%) P (%) F-measure AUC
AAP* 59.860.9 58.566.5 0.59060.040 0.667
BCPred* 54.067.1 60.562.5 0.57260.055 0.667
SVMTriP 80.162.1 55.261.0 0.69360.060 0.702
*The results for AAP [14] and BCPred [15], are obtained by the software
implemented locally.
doi:10.1371/journal.pone.0045152.t002
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most cases, the three methods returned more virus peptide than
human peptides within the top-ranked peptides. SVMTriP,
however, selected higher percentage of virus peptides than both
AAP and BCPred. For example, in total 400 top-ranked peptides
returned by SVMTriP, 90.5% of them, i.e. 362, are virus peptides.
There are 47.8% (191), 56.5% (226) virus peptides returning by
AAP and BCPred, respectively. This indicates the exceptional
ability of SVMTriP to distinguish epitopic and non-epitopic
peptides.
Discussion
Prediction with tri-peptide propensity alone
The propensity of tri-peptide alone is tested and the result is
shown in Table 4. The prediction sensitivity and precision are
56.5% bad 61.0%, respectively, similar to those of AAP, which is
based on bi-peptide propensity and yielded a sensitivity of 59.8%
and precision of 58.5% for the same test set. This result indicates
that combining similarity scores is essential for the tri-peptide
model to achieve a better performance.
Prediction with tri-peptide similarity alone
The tri-peptide similarity scores can be calculated with either
Blosum62 or PAM160 matrixes. The performance of two different
matrices for the tri-peptide model is evaluated with the same
procedure of the five-fold cross-validation for 20AA-length
epitopes. The results are shown in Table 4. Without the propensity
score, using Blosum62 matrix shows similar performance as using
the PAM160. However, when combined with the propensity score,
Blosum62 matrix leads to a higher prediction performance.
Discrete tri-peptide subsequence models
We also implement a method that uses the space of tetra-
peptide subsequence with one mismatch, i.e. discrete tri-peptide
subsequences. For this case, the subsequences are considered in
patterns like A_AA or AA_A, where ‘A’ represents the amino acid
residue to be considered, and ‘_’ represents the residue position
that will be ignored in the comparison. The number of SVM
attributes is still 203, which is identical to that of the tri-peptide
model. Interestingly, without considering propensity scores, the
subsequence models of A_AA and AA_A patterns have similar
sensitivity and precision with the tri-peptide model. However, the
combination of similarity and propensity of the tri-peptide model
significantly enhances the performance, while addition of the
propensity does not increase sensitivity or precision for A_AA and
AA_A patterns. The result is shown in Table 4. This finding
indicates that the propensity is more important for the tri-peptide
model than the discrete tri-peptide subsequence model.
Conclusion
The performance for linear B-cell epitope prediction is
improved by concurrently using similarity and propensity of the
Figure 2. Tendency test for BCPred, AAP, and SVMTriP. Three bars at the same point on the x-axis are the results for APP (blue), BCPred
(green), and SVMTriP (red), respectively. In the same bar, the light part is for the number of returned human peptide, and the dark part is for virus. For
example, at the point of 400 returned peptides, the dark part in the red bar is 362, which means that 362 viral peptides are return in all 400 peptides
by SVMTriP, and the light red part represents 38 human peptides.
doi:10.1371/journal.pone.0045152.g002
Table 3. Weights of tri-peptides in the optimal SVM model.
Tri-Peptide Rank
Weight
Score* Tri-Peptide Rank
Weight
Score*
QQP 1 503251.79 GQQ 11 121677.62
PQQ 2 488627.71 QPY 12 116598.60
QPQ 3 367386.40 YPQ 13 113237.37
QPF 4 246462.39 QQF 14 81709.59
FPQ 5 234868.65 PYP 15 79191.37
PQP 6 231353.73 FQQ 16 77357.97
QGQ 7 153161.76 PPP 17 76320.05
PFP 8 151840.02 QPP 18 64756.05
QQQ 9 128930.20 QFP 19 63814.16
QQG 10 122291.90 PPQ 20 63173.33
*Weight scores are calculated by the formula w=g a ixi. Here a is dual
representation of the decision boundary; and xi (i = 0, 1, 2…n) is vector
described in SVM model. Both a i and xi are available in model file.
doi:10.1371/journal.pone.0045152.t003
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tri-peptide model. Combination of similarity and propensity gives
rise to an excellent performance for the tri-peptide model, but does
not for the discrete tri-peptide subsequence model. SVMTriP
finally achieved the AUC value of 0.702 and, at the point with the
maximal F-measure, Sn = 80.1% and P= 55.2%. Further more,
SVMTriP is capable of distinguishing virus peptides from human
ones, and hence, has a higher chance to correctly predict linear B-
cell epitopes. The web server, trained models, and all datasets are
available at http://sysbio.unl.edu/SVMTriP.
Materials and Methods
Datasets
The dataset is constructed by extracting non-redundant linear
B-cell epitopes from IEDB [9], because it is frequently updated
and has a large number of linear epitopes. Total of 65,456 B-cell
linear epitopes are downloaded from IEDB (version June 11th,
2012). The identical epitopes and those possibly related to T-cell
are removed. The full-length sequences of corresponding epitopes
are also collected. The various lengths of epitope sequences,
including 10AA, 12AA, 14AA, 16AA, 18AA, and 20AA, are
extracted by trimming the long experimental measured epitopes or
attaching more amino acid residues to both ends of short epitopes
according to the full-length sequences. For a given length, epitope
sequences with $30% similarity, measured by BLAST [24], are
clustered together and only one of them is kept as an epitope
sequence in the dataset. Finally, the dataset for each length has a
total of 4925 non-redundant epitope sequences. For the negative
dataset, the same numbers of equal-length sub-sequences are
extracted from the non-epitopic segments in the corresponding
antigen sequences.
Support Vector Machine Setup
Attribute encoding. The tri-peptide subsequence space is
used to encode the SVM attributes. This kernel has a space of 203
attributes for both tri-peptide substring and propensity. The score
of i-th attribute, K(i), is defined as the tri-peptide subsequence
similarity kernel modulated by its corresponding tri-peptide
propensity. Please see Equation (1):
K ið Þ~T (i).P(i), ð1Þ
where K(i) denotes the score of the i-th attribute, T (i) denotes the
i-th tri-peptide subsequence similarity kernel, and P(i) denotes
corresponding tri-peptide subsequence propensity of i-th tri-
peptide subsequence. The tri-peptide subsequence similarity
kernel is defined as:
T ið Þ~
X
W ið Þ6Vj , ð2Þ
where W(i) denotes the tri-peptide that represents the i-th
attribute, Vj denotes the j-th tri-peptide in the tri-peptide
subsequence space for the input sequence. The symbol ‘‘:’’
denotes getting the similarity score of any two corresponding tri-
peptide, i.e. sum of three similarity scores for three amino acid
pairs from a Blosum/PAM matrix. For example, assuming the
length of a given epitope candidate is 20 AA, the tri-peptide
subsequence similarity kernel for the i-th attribute is generated by
summing over similarity scores of the 18 pairs of tri-peptides; each
pair consists of one tri-peptide from the input sequence and the tri-
peptide represents i-th attribute from the tri-peptide subsequence
space. This subsequence kernel was previously used to predict
protein subcellular localization by Lei and Dai [25]. The
propensity of tri-peptide subsequence representing the i-th
attribute is calculated as in Equation (3):
P(i)~
f (i)
F (i)
, ð3Þ
where f(i) is the frequency of i-th type of tri-peptide in the positive
epitopes, and F(i) is the frequency of i-th type of tri-peptide in
56104 protein sequences randomly selected from the Refseq
database [23].
Training/Prediction procedure. The SVM training in this
work uses an SVM package, SVMlight, implemented by Joachims
(http://svmlight.joachims.org/) [26]. All SVM parameters are
Table 4. Comparison among the tri-peptide subsequence models with or without propensity.
Kernels Sn (%) P (%) F-measure
Tri-peptide Propensity only N.A. 56.5612.5 61.066.3 0.58460.085
Tri-peptide w./o. Propensity Blosum62 54.566.5 60.561.5 0.57360.035
PAM160 55.067.2 61.161.8 0.57860.040
w./Propensity Blosum
62*
80.1±
2.1
55.2±
1.0
0.693±
0.060
PAM160 69.3610.0 58.563.5 0.63360.050
AA_A pattern w./o. Propensity Blosum62 54.866.8 60.561.5 0.57960.040
PAM160 55.267.1 61.362.0 0.57760.045
w./Propensity Blosum62 60.565.5 57.562.5 0.58960.040
PAM160 59.565.5 57.561.5 0.58560.035
A_AA pattern w./o. Propensity Blosum62 55.568.5 60.662.2 0.58160.050
PAM160 55.268.1 60.561.5 0.57760.055
w./Propensity Blosum62 60.566.5 57.561.5 0.59060.040
PAM160 59.565.5 57.561.5 0.58560.025
*The corresponding model is defined as SVMTriP.
doi:10.1371/journal.pone.0045152.t004
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optimized by a grid search (c=2210,21, g=2212,23, and
p=225,22). For each grid point of the triplets, a five-fold cross-
validation procedure is employed to evaluate the performance of
the trained SVM model. To carry out the five-fold validation
procedure, the total of 4925 positive epitopes are split into five
groups, and any two-epitope sequences from two different groups
do not have sequence similarity more than 20%. At each triplet
point, the maximum F-measure is calculated. The optimal
parameter set has the largest value in all points by the maximum
F-measures. During the procedure of five-fold validation, five test
results are used to calculate the mean values and 95% confidence
intervals of sensitivity, precision, and the maximal F-measure.
For the application on the online server, the prediction model is
obtained by training the whole dataset with the same numbers of
positive and negative epitopes. To predict a given full-length
protein sequence, the sliding window method is employed to
obtain subsequences with variable lengths, including 10AA, 12AA,
14AA, 16AA, 18AA, and 20AA. For each subsequence, SVMTriP
calculates its score, and a positive score indicates that the
subsequence is a putative antigenic epitope.
Evaluation methods
The statistical terms, sensitivity (Sn), precision (P), and F-
measure, are defined in the following equations:
Sn~
TP
TPzFN
|100%
P~
TP
TPzFP
|100%
F~
2|P|Sn
PzSn
,
where TP, TN, FP, and FP stand for true positive, true negative,
false positive, and false negative, respectively. F-measure is used to
determine the optimal prediction results. A java program available
at http://pages.cs.wisc.edu/,richm/programs/AUC/ is used to
calculate the AUC. The online tool StAR [27,28] is used to test
whether the difference between ROC curves resulting from two
methods is statistically significant.
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